Study of Personalized Mobile Health Application to Improve Recovery After Reverse Shoulder Arthroplasty Surgery
Led by VieCuri Medical Centre · Updated on 2026-08-24
170
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of a personalized mobile health mHealth application to support recovery after reverse shoulder arthroplasty RSA surgery, specifically for patients with shoulder osteoarthritis. The study aims to compare interactive, tailored information and rehabilitation protocols delivered via the app against standard generic information and rehabilitation to see if the personalized approach improves postoperative recovery. This research involves a randomized controlled trial conducted in two Dutch hospitals.
Participants will be randomly assigned to either the intervention group, which receives daily interactive and personalized rehabilitation guidance through an mHealth app, or the control group, which receives standard care information and rehabilitation via a non-interactive app. Both groups undergo primary elective RSA surgery. The personalized app adjusts the timing, amount, and type of exercises based on patient needs throughout the rehabilitation period.
During the study, participants will be monitored for shoulder function using the Oxford Shoulder Score at multiple intervals up to one year after surgery. Other assessments include shoulder pain, disability, range of motion, satisfaction with the app, length of hospital stay, complication rates, and readmission rates. The study collects data at baseline and follow-up points at six weeks, three months, and one year to assess recovery progress and treatment satisfaction.
CONDITIONS
Brief Title
Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Additional muscle transfer required during surgery
Unable to read and understand Dutch
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Treatment
Duration - Up to 1 year
Participants receive either a personalized interactive mobile app for rehabilitation or standard care with a non-interactive app after reverse shoulder arthroplasty surgery.
Assessments at baseline, 6 weeks, 3 months, and 1 year
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study to Confirm Safety and Performance of the AETOS Shoulder System in Primary Anatomic and Reverse Shoulder Replacement Surgery
Study of Epidiolex CBD to Help Reduce Pain After Rotator Cuff Shoulder Surgery
Study Comparing Myofascial Trigger Point Injection and Joint Cavity Injection for Treating Shoulder Osteoarthritis Pain in Adults 45 and Older
Randomized Study Comparing Interscalene Catheter and Liposomal Bupivacaine Single Injection for Pain Control After Total Shoulder Replacement Surgery
Comparing Pain Relief from Two Shoulder Injections Cingal Versus Cortisone
Randomized Trial in Adults with Moderate to Severe Shoulder Osteoarthritis
Pilot Study of a Wearable Feedback Device to Help Manage Work-Related Shoulder Pain in Adult Workers
Comparing Outcomes of Two Reverse Shoulder Replacement Types BIO-RSA Versus Conventional RSA in Patients Aged 45 to 80
Comparing Metal and Bone Lateralization in Reverse Shoulder Arthroplasty for Osteoarthritis and Related Conditions Using CT Motion Analysis
Study of Personalized Mobile Health Application to Improve Recovery After Reverse Shoulder Arthroplasty Surgery
Comparing Single Injections of Low-dose and High-dose Platelet-rich Plasma to Saline in Glenohumeral Osteoarthritis A Randomized Controlled Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Optimizing recovery after reverse shoulder arthroplasty with a personalised mobile health application compared to generic digital information: a protocol of a multicentre randomised controlled trial.
J R W Crutsen, F O Lambers Heerspink, A Kornuijt...